|
DE1249281B
(enExample)
|
1963-05-18 |
|
|
|
|
US3691016A
(en)
|
1970-04-17 |
1972-09-12 |
Monsanto Co |
Process for the preparation of insoluble enzymes
|
|
DE2027645A1
(de)
|
1970-06-05 |
1971-12-09 |
Byk Gulden Lomberg Chemische Fa bnk GmbH, 7750 Konstanz |
Piperazinylalkyl chinazolon (4) den vate, Verfahren zu deren Herstellung und sie enthaltende Arzneimittel
|
|
US3897432A
(en)
|
1971-04-21 |
1975-07-29 |
Merck & Co Inc |
Substituted benzimidazole derivatives
|
|
NL7204972A
(enExample)
|
1971-04-21 |
1972-10-24 |
|
|
|
CA1023287A
(en)
|
1972-12-08 |
1977-12-27 |
Boehringer Mannheim G.M.B.H. |
Process for the preparation of carrier-bound proteins
|
|
US4179337A
(en)
|
1973-07-20 |
1979-12-18 |
Davis Frank F |
Non-immunogenic polypeptides
|
|
US4195128A
(en)
|
1976-05-03 |
1980-03-25 |
Bayer Aktiengesellschaft |
Polymeric carrier bound ligands
|
|
DE2644265C2
(de)
|
1976-09-30 |
1983-02-10 |
Bayer Ag, 5090 Leverkusen |
Chinazoline
|
|
US4330440A
(en)
|
1977-02-08 |
1982-05-18 |
Development Finance Corporation Of New Zealand |
Activated matrix and method of activation
|
|
CA1093991A
(en)
|
1977-02-17 |
1981-01-20 |
Hideo Hirohara |
Enzyme immobilization with pullulan gel
|
|
US4183931A
(en)
|
1977-09-08 |
1980-01-15 |
Research Corporation |
2-Ketoalkyl-4(3H)-quinazolinones
|
|
US4229537A
(en)
|
1978-02-09 |
1980-10-21 |
New York University |
Preparation of trichloro-s-triazine activated supports for coupling ligands
|
|
DE2812635A1
(de)
|
1978-03-22 |
1979-09-27 |
Bayer Ag |
Heterocyclische verbindungen
|
|
JPS55118917A
(en)
|
1979-03-06 |
1980-09-12 |
Mitsubishi Electric Corp |
Production of quinazolone ring-containing epoxy resin
|
|
JPS55118918A
(en)
|
1979-03-06 |
1980-09-12 |
Mitsubishi Electric Corp |
Production of quinazolone ring-containing epoxy resin
|
|
US4289872A
(en)
|
1979-04-06 |
1981-09-15 |
Allied Corporation |
Macromolecular highly branched homogeneous compound based on lysine units
|
|
JPS6017375B2
(ja)
|
1979-06-20 |
1985-05-02 |
三菱電機株式会社 |
ポリアミド樹脂の製造方法
|
|
JPS6023084B2
(ja)
|
1979-07-11 |
1985-06-05 |
味の素株式会社 |
代用血液
|
|
US4640835A
(en)
|
1981-10-30 |
1987-02-03 |
Nippon Chemiphar Company, Ltd. |
Plasminogen activator derivatives
|
|
US4496689A
(en)
|
1983-12-27 |
1985-01-29 |
Miles Laboratories, Inc. |
Covalently attached complex of alpha-1-proteinase inhibitor with a water soluble polymer
|
|
DE3675588D1
(de)
|
1985-06-19 |
1990-12-20 |
Ajinomoto Kk |
Haemoglobin, das an ein poly(alkenylenoxid) gebunden ist.
|
|
US4791192A
(en)
|
1986-06-26 |
1988-12-13 |
Takeda Chemical Industries, Ltd. |
Chemically modified protein with polyethyleneglycol
|
|
CH671155A5
(enExample)
|
1986-08-18 |
1989-08-15 |
Clinical Technologies Ass |
|
|
USRE35862E
(en)
|
1986-08-18 |
1998-07-28 |
Emisphere Technologies, Inc. |
Delivery systems for pharmacological agents encapsulated with proteinoids
|
|
US6696250B1
(en)
|
1986-12-03 |
2004-02-24 |
Competitive Technologies, Inc. |
RNA ribozyme polymerases, dephosphorylases, restriction endoribonucleases and methods
|
|
US5229490A
(en)
|
1987-05-06 |
1993-07-20 |
The Rockefeller University |
Multiple antigen peptide system
|
|
WO1989008113A1
(en)
|
1988-03-02 |
1989-09-08 |
Yoshitomi Pharmaceutical Industries, Ltd. |
3,4-DIHYDROTHIENO[2,3-d]PYRIMIDINE COMPOUNDS AND PHARMACEUTICAL APPLICATION THEREOF
|
|
US5225347A
(en)
|
1989-09-25 |
1993-07-06 |
Innovir Laboratories, Inc. |
Therapeutic ribozyme compositions and expression vectors
|
|
US5013556A
(en)
|
1989-10-20 |
1991-05-07 |
Liposome Technology, Inc. |
Liposomes with enhanced circulation time
|
|
FR2675803B1
(fr)
|
1991-04-25 |
1996-09-06 |
Genset Sa |
Oligonucleotides fermes, antisens et sens et leurs applications.
|
|
DK0525960T3
(da)
|
1991-06-18 |
1996-04-15 |
American Home Prod |
Anvendelse af rapamycin til behandling af T-celle leukæmi/lymfon
|
|
WO1993021259A1
(en)
|
1992-04-14 |
1993-10-28 |
Cornell Research Foundation Inc. |
Dendritic based macromolecules and method of production
|
|
US5658780A
(en)
|
1992-12-07 |
1997-08-19 |
Ribozyme Pharmaceuticals, Inc. |
Rel a targeted ribozymes
|
|
GB9301000D0
(en)
|
1993-01-20 |
1993-03-10 |
Glaxo Group Ltd |
Chemical compounds
|
|
US5378725A
(en)
|
1993-07-19 |
1995-01-03 |
The Arizona Board Of Regents |
Inhibition of phosphatidylinositol 3-kinase with wortmannin and analogs thereof
|
|
GB9404485D0
(en)
|
1994-03-09 |
1994-04-20 |
Cancer Res Campaign Tech |
Benzamide analogues
|
|
FI951367A7
(fi)
|
1994-03-28 |
1995-09-29 |
Japan Energy Corp |
Puriinijohdannaiset ja tulehdustautien tukahduttajat (suppressantit)
|
|
US5480906A
(en)
|
1994-07-01 |
1996-01-02 |
Eli Lilly And Company |
Stereochemical Wortmannin derivatives
|
|
EP1157698A3
(en)
|
1994-08-12 |
2002-05-02 |
Pro-Neuron, Inc. |
Treatment of inflammatory diseases with oxypurine nucleosides
|
|
US5561138A
(en)
|
1994-12-13 |
1996-10-01 |
American Home Products Corporation |
Method of treating anemia
|
|
JP3233802B2
(ja)
|
1994-12-15 |
2001-12-04 |
関西電力株式会社 |
燃焼排ガス中の炭酸ガスと窒素酸化物を除去する方法
|
|
US6043062A
(en)
|
1995-02-17 |
2000-03-28 |
The Regents Of The University Of California |
Constitutively active phosphatidylinositol 3-kinase and uses thereof
|
|
US6096871A
(en)
|
1995-04-14 |
2000-08-01 |
Genentech, Inc. |
Polypeptides altered to contain an epitope from the Fc region of an IgG molecule for increased half-life
|
|
US5948664A
(en)
|
1996-02-29 |
1999-09-07 |
The Regents Of The University Of California |
PI 3-kinase polypeptides
|
|
WO1997034631A1
(en)
|
1996-03-18 |
1997-09-25 |
Board Of Regents, The University Of Texas System |
Immunoglobin-like domains with increased half lives
|
|
ES2198546T3
(es)
|
1996-05-15 |
2004-02-01 |
Pfizer Inc. |
4(3h)-quinazolinonas 2,3,6 trisustituidas.
|
|
GB9611460D0
(en)
|
1996-06-01 |
1996-08-07 |
Ludwig Inst Cancer Res |
Novel lipid kinase
|
|
US5858753A
(en)
|
1996-11-25 |
1999-01-12 |
Icos Corporation |
Lipid kinase
|
|
PT958296E
(pt)
|
1996-12-31 |
2003-11-28 |
Reddys Lab Ltd Dr |
Compostos heterociclicos processo para a sua preparacao composicoes farmaceuticas contendo-os e sua utilizacao no tratamento da diabetes e doencas relacionadas
|
|
GB9702701D0
(en)
|
1997-02-01 |
1997-04-02 |
Univ Newcastle Ventures Ltd |
Quinazolinone compounds
|
|
EP0964860B1
(en)
|
1997-02-28 |
2004-04-21 |
Pfizer Products Inc. |
Atropisomers of 3-heteroaryl-4(3h)-quinazolinones for the treatment of neurodegenerative and cns-trauma related conditions
|
|
ATE267817T1
(de)
|
1997-02-28 |
2004-06-15 |
Pfizer Prod Inc |
Atropisomere von 3-aryl-4(3h)-chinazolinonen und ihre verwendung als ampa-rezeptor
|
|
EP0884310B1
(en)
|
1997-06-09 |
2005-09-07 |
Pfizer Products Inc. |
Quinazolin-4-one ampa antagonists
|
|
WO1999001139A1
(en)
|
1997-07-03 |
1999-01-14 |
Thomas Jefferson University |
An improved method for design and selection of efficacious antisense oligonucleotides
|
|
IL125950A0
(en)
|
1997-09-05 |
1999-04-11 |
Pfizer Prod Inc |
Methods of administering ampa receptor antagonists to treat dyskinesias associated with dopamine agonist therapy
|
|
CA2317093A1
(en)
|
1998-01-08 |
1999-07-15 |
Joel M. Linden |
A2a adenosine receptor agonists
|
|
WO1999008501A2
(en)
|
1998-04-23 |
1999-02-25 |
Dr. Reddy's Research Foundation |
New heterocyclic compounds and their use in medicine, process for their preparation and pharmaceutical compositions containing them
|
|
US6048970A
(en)
|
1998-05-22 |
2000-04-11 |
Incyte Pharmaceuticals, Inc. |
Prostate growth-associated membrane proteins
|
|
US6100090A
(en)
|
1999-06-25 |
2000-08-08 |
Isis Pharmaceuticals Inc. |
Antisense inhibition of PI3K p85 expression
|
|
US6046049A
(en)
|
1999-07-19 |
2000-04-04 |
Isis Pharmaceuticals Inc. |
Antisense modulation of PI3 kinase p110 delta expression
|
|
WO2001081346A2
(en)
|
2000-04-25 |
2001-11-01 |
Icos Corporation |
Inhibitors of human phosphatidyl-inositol 3-kinase delta
|
|
EP1939203B1
(en)
|
2000-04-25 |
2014-11-19 |
ICOS Corporation |
Inhibitors of human phosphatidyl-inositol 3-kinase delta isoform
|
|
US6667300B2
(en)
|
2000-04-25 |
2003-12-23 |
Icos Corporation |
Inhibitors of human phosphatidylinositol 3-kinase delta
|
|
US20040092561A1
(en)
|
2002-11-07 |
2004-05-13 |
Thomas Ruckle |
Azolidinone-vinyl fused -benzene derivatives
|
|
CA2493843C
(en)
|
2002-07-10 |
2012-04-17 |
Applied Research Systems Ars Holding N.V. |
Azolidinone-vinyl fused-benzene derivatives
|
|
GB0217777D0
(en)
|
2002-07-31 |
2002-09-11 |
Novartis Ag |
Organic compounds
|
|
US20040023390A1
(en)
|
2002-08-05 |
2004-02-05 |
Davidson Beverly L. |
SiRNA-mediated gene silencing with viral vectors
|
|
CA2400254A1
(en)
|
2002-09-19 |
2004-03-19 |
University Health Network |
Compositions and methods for treating heart disease
|
|
ATE411996T1
(de)
|
2002-09-30 |
2008-11-15 |
Bayer Healthcare Ag |
Kondensierte azolpyrimidinderivate
|
|
JP2006510661A
(ja)
|
2002-12-06 |
2006-03-30 |
ワーナー−ランバート・カンパニー、リミテッド、ライアビリティ、カンパニー |
Ｐｉ３ｋの阻害剤としてのベンズオキサジン−３−オン類及びその誘導体
|
|
WO2004056820A1
(en)
|
2002-12-20 |
2004-07-08 |
Warner-Lambert Company Llc |
Benzoxazines and derivatives thereof as inhibitors of pi3ks
|
|
EP1611119A1
(en)
|
2003-04-03 |
2006-01-04 |
Semafore Pharmaceuticals, Inc. |
Pi-3 kinase inhibitor prodrugs
|
|
US20040259926A1
(en)
|
2003-06-05 |
2004-12-23 |
Bruendl Michelle M. |
3-Aryloxy and 3-heteroaryloxy substituted benzo[b]thiophenes as therapeutic agents
|
|
MXPA05013210A
(es)
|
2003-06-05 |
2006-03-09 |
Warner Lambert Co |
Benzo[b]tiofenos cicloalquilsulfanil-sustituidos como agentes terapeuticos.
|
|
BRPI0411092A
(pt)
|
2003-06-05 |
2006-07-18 |
Warner Lambert Co |
benzo[b]tiofenos substituìdos com 3-arilsulfanila e com 3-heteroarilsulfanila como agentes terapêuticos
|
|
WO2004108709A1
(en)
|
2003-06-05 |
2004-12-16 |
Warner-Lambert Company Llc |
Tetrazol benzofurancarboxamides with p13k aktivity as therapeutic agents
|
|
JP2006526605A
(ja)
|
2003-06-05 |
2006-11-24 |
ワーナー−ランバート カンパニー リミティド ライアビリティー カンパニー |
治療剤としての３−置換インドール類及びそれらの誘導体
|
|
EP1636210A1
(en)
|
2003-06-05 |
2006-03-22 |
Warner-Lambert Company LLC |
Cycloalkyl and heterocycloalkyl substituted benzothiophenes as therapeutic agents
|
|
US20050054614A1
(en)
|
2003-08-14 |
2005-03-10 |
Diacovo Thomas G. |
Methods of inhibiting leukocyte accumulation
|
|
US20050043239A1
(en)
|
2003-08-14 |
2005-02-24 |
Jason Douangpanya |
Methods of inhibiting immune responses stimulated by an endogenous factor
|
|
WO2005067901A2
(en)
|
2004-01-08 |
2005-07-28 |
Michigan State University |
Methods for treating and preventing hypertension and hypertension-related disorders
|
|
EP1750714A1
(en)
|
2004-05-13 |
2007-02-14 |
Vanderbilt University |
Phosphoinositide 3-kinase delta selective inhibitors for inhibiting angiogenesis
|
|
ES2607804T3
(es)
|
2004-05-13 |
2017-04-04 |
Icos Corporation |
Quinazolinones como inhibidores de la fosfatidilinositol humana 3-quinasa delta
|
|
JP2008500338A
(ja)
|
2004-05-25 |
2008-01-10 |
イコス・コーポレイション |
造血細胞の異常増殖を治療及び／又は予防する方法
|
|
CN101123968A
(zh)
*
|
2004-06-04 |
2008-02-13 |
艾科斯有限公司 |
肥大细胞病的治疗方法
|
|
EP1885356A2
(en)
|
2005-02-17 |
2008-02-13 |
Icos Corporation |
Phosphoinositide 3-kinase inhibitors for inhibiting leukocyte accumulation
|
|
WO2007076085A2
(en)
|
2005-12-22 |
2007-07-05 |
Prolexys Pharmaceuticals, Inc . |
Fused pyrimidones and thiopyrimidones, and uses thereof
|
|
EP2097422A4
(en)
|
2006-11-13 |
2010-04-14 |
Lilly Co Eli |
THIENOPYRIMIDINONE FOR THE TREATMENT OF INFLAMMATORY DISEASES AND CARCINOMAS
|
|
WO2009046448A1
(en)
|
2007-10-04 |
2009-04-09 |
Intellikine, Inc. |
Chemical entities and therapeutic uses thereof
|
|
US20090131512A1
(en)
|
2007-10-31 |
2009-05-21 |
Dynavax Technologies Corp. |
Inhibition of type I in IFN production
|
|
KR101653842B1
(ko)
|
2008-01-04 |
2016-09-02 |
인텔리카인, 엘엘씨 |
특정 화학 물질, 조성물 및 방법
|
|
CN102271683B
(zh)
|
2008-11-13 |
2014-07-09 |
吉里德卡利斯托加公司 |
恶性血液病的治疗
|
|
CA2745280A1
(en)
|
2008-12-04 |
2010-06-10 |
The United States Of America, As Represented By The Secretary, Departmen T Of Health And Human Services |
Phosphatidylinositol-3-kinase p110 delta-targeted drugs in the treatment of cns disorders
|
|
AU2010229968A1
(en)
|
2009-03-24 |
2011-10-13 |
Gilead Calistoga Llc |
Atropisomers of2-purinyl-3-tolyl-quinazolinone derivatives and methods of use
|
|
EP2421536B1
(en)
|
2009-04-20 |
2015-08-26 |
Gilead Calistoga LLC |
Methods of treatment for solid tumors
|
|
US8691829B2
(en)
*
|
2009-07-21 |
2014-04-08 |
Gilead Calistoga Llc |
Treatment of liver disorders with PI3K inhibitors
|
|
NZ717373A
(en)
|
2010-06-03 |
2017-11-24 |
Pharmacyclics Llc |
The use of inhibitors of bruton’s tyrosine kinase (btk)
|